Introduction
Zinc L-carnosine (ZnC), also known as polaprezinc, is a chelated compound combining zinc and the dipeptide L-carnosine in a 1:1 molar ratio. Originally developed in Japan, ZnC has been utilized for over two decades in the treatment of gastric ulcers and other gastrointestinal (GI) disorders. Its unique structure allows for targeted delivery and prolonged retention at mucosal injury sites, facilitating tissue repair and exerting antioxidant and anti-inflammatory effects. This review delves into the current scientific understanding of ZnC’s mechanisms and therapeutic applications, focusing on its impact on stomach tissue, intestinal lining, and its general antioxidant and anti-inflammatory properties.(Natural Medicine Journal)
1. Gastroprotective Effects on Stomach Tissue
1.1 Protection Against Ethanol-Induced Gastric Damage
Ethanol consumption can lead to significant gastric mucosal injury. A study by Odashima et al. demonstrated that ZnC administration in rats effectively prevented ethanol-induced gastric mucosal damage without altering prostaglandin E2 levels, suggesting a prostaglandin-independent protective mechanism . Histological assessments revealed that ZnC inhibited deep mucosal necrosis, highlighting its cytoprotective properties.(PubMed)
1.2 Enhancement of Heat Shock Protein Expression
Heat shock proteins (HSPs) play a crucial role in cellular protection against stress. Research indicates that ZnC induces the expression of HSP72 in gastric mucosa, which contributes to its protective effects against mucosal injury. In a rat model of portal hypertensive gastropathy, ZnC administration led to increased HSP72 expression and reduced mucosal damage .(PubMed)
1.3 Membrane-Stabilizing Action
ZnC exhibits membrane-stabilizing properties, which are vital in maintaining cellular integrity under stress conditions. Studies have shown that ZnC can stabilize lysosomal membranes, reducing the release of harmful enzymes like beta-glucuronidase, thereby protecting gastric mucosal cells from damage .(PubMed)
2. Protective Effects on Intestinal Lining
2.1 Mitigation of Colonic Mucosal Injury
Inflammatory bowel diseases (IBDs) involve chronic inflammation of the intestinal tract. In a study investigating ZnC’s effects on acetic acid-induced colonic injury in rats, ZnC administration resulted in significant protection of the colonic mucosa. This protective effect was associated with increased expression of HSP72 and suppression of NF-ÎşB activation, a key regulator of inflammatory responses .(PubMed)
2.2 Improvement of Intestinal Barrier Function
ZnC has been reported to enhance intestinal barrier integrity, which is often compromised in various GI disorders. By strengthening tight junctions between epithelial cells, ZnC helps prevent the translocation of harmful substances from the gut lumen into the bloodstream, thereby reducing systemic inflammation .(Taylor & Francis Online, ScienceDirect)
3. Antioxidant Properties
Oxidative stress plays a pivotal role in the pathogenesis of many GI diseases. ZnC exhibits potent antioxidant properties by scavenging reactive oxygen species (ROS) and inhibiting lipid peroxidation. In a rat model of ischemia-reperfusion-induced gastric injury, ZnC administration significantly reduced mucosal damage and lipid peroxide levels, indicating its efficacy in combating oxidative stress .(PubMed)
4. Anti-Inflammatory Mechanisms
4.1 Suppression of NF-ÎşB Activation
NF-ÎşB is a transcription factor that regulates the expression of various pro-inflammatory genes. Studies have demonstrated that ZnC can suppress NF-ÎşB activation in macrophages stimulated with lipopolysaccharide (LPS), leading to decreased production of inflammatory mediators such as nitric oxide and cytokines .(PubMed)
4.2 Activation of Nrf2/HO-1 Pathway
The Nrf2/HO-1 pathway is a critical cellular defense mechanism against oxidative stress and inflammation. ZnC has been shown to activate this pathway, resulting in increased expression of heme oxygenase-1 (HO-1), an enzyme with anti-inflammatory and antioxidant functions. This activation contributes to ZnC’s protective effects in inflammatory conditions .
5. Clinical Applications and Safety Profile
ZnC has been widely used in clinical settings for the treatment of various GI disorders, including peptic ulcers, gastritis, and mucositis induced by chemotherapy or radiotherapy. Its safety profile is favorable, with minimal reported side effects. The compound’s ability to adhere to damaged mucosa and release zinc locally enhances its therapeutic efficacy while minimizing systemic exposure .(ScienceDirect)
Conclusion
Zinc L-carnosine is a multifaceted compound with significant therapeutic potential in gastrointestinal health. Its ability to protect and heal mucosal tissues, coupled with its antioxidant and anti-inflammatory properties, makes it a valuable agent in the management of various GI disorders. Further research and clinical trials will continue to elucidate its full range of benefits and applications in human health.
References:
- Odashima M, et al. “Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats.” PubMed, 1990. (PubMed)
- Mikami K, et al. “Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72.” PubMed, 2006. (PubMed)
- Odashima M, et al. “Zinc L-carnosine protects colonic mucosal injury through induction of heat shock protein 72 and suppression of NF-kappaB activation.” PubMed, 2006. (PubMed)
- Matsukura T, et al. “Effect of zinc-carnosine chelate compound (Z-103), a novel antioxidant, on acute gastric mucosal injury induced by ischemia-reperfusion in rats.” PubMed, 1991. (PubMed)
- Tanaka H, et al. “Zinc Carnosine Inhibits Lipopolysaccharide-Induced Inflammatory Mediators by Suppressing NF-ÎşB Activation in Raw 264.7 Macrophages, Independent of the MAPKs Signaling Pathway.” PubMed, 2016. (PubMed)
- Tanaka H, et al. “Zinc L-carnosine suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 murine macrophages cell line via activation of Nrf2/HO-1 signaling pathway.” PubMed, 2017. (Taylor & Francis Online)
- Hudson T. “Nutrient Profile: Zinc-Carnosine.” Natural Medicine Journal, 2014. (Natural Medicine Journal)
- Scarpignato C, et al. “The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review.” ScienceDirect, 2022. (ScienceDirect)
- Tanaka H, et al. “The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats.” PubMed, 1991. (PubMed)
- Matsukura T, et al. “Studies on anti-ulcer effects of a new compound, zinc L-carnosine (Z-103).” PubMed, 1990. (PubMed)
Note: This article is a synthesis of current research findings on zinc L-carnosine and is intended for informational purposes. For personalized medical advice, please consult a healthcare professional.
